Monogram Technologies Inc. financial data

Symbol
MGRM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
53 Bridge Street Unit 507, Brooklyn, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
MONOGRAM ORTHOPAEDICS INC (to 5/17/2024)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 530 % +217%
Quick Ratio 0.07 %
Debt-to-equity 23 % -80.4%
Return On Equity -131 % +28.1%
Return On Assets -106 % -27.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.3M shares +10.2%
Common Stock, Shares, Outstanding 34.3M shares +17.1%
Entity Public Float 77.2M USD
Common Stock, Value, Issued 34.3K USD +17.1%
Weighted Average Number of Shares Outstanding, Basic 32.2M shares +10%
Weighted Average Number of Shares Outstanding, Diluted 32.2M shares +10%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10.1M USD +4.23%
Selling and Marketing Expense 2.2M USD -31.7%
General and Administrative Expense 4.38M USD +17.6%
Operating Income (Loss) -16.3M USD +1.93%
Nonoperating Income (Expense) 535K USD -84.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.7M USD -19.2%
Net Income (Loss) Attributable to Parent -15.7M USD -19.2%
Earnings Per Share, Basic -0.29 USD/shares +71.6%
Earnings Per Share, Diluted -0.29 USD/shares +71.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.6M USD +11.4%
Accounts Receivable, after Allowance for Credit Loss, Current 365K USD
Inventory, Net 290K USD +6281%
Other Assets, Current 14.7K USD -98.9%
Assets, Current 18.6M USD +15.3%
Property, Plant and Equipment, Net 829K USD -14.8%
Operating Lease, Right-of-Use Asset 371K USD -25.6%
Intangible Assets, Net (Excluding Goodwill) 391K USD -34.9%
Assets 20.2M USD +10.9%
Accounts Payable, Current 1.54M USD -13.9%
Employee-related Liabilities, Current 589K USD
Accrued Liabilities, Current 875K USD +58.7%
Liabilities, Current 2.55M USD -57.3%
Operating Lease, Liability, Noncurrent 261K USD -34.2%
Liabilities 2.81M USD -55.9%
Retained Earnings (Accumulated Deficit) -63.7M USD -33.1%
Stockholders' Equity Attributable to Parent 17.4M USD +46.7%
Liabilities and Equity 20.2M USD +10.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.65M USD -26.7%
Net Cash Provided by (Used in) Financing Activities 151K USD +2.49%
Net Cash Provided by (Used in) Investing Activities -11.4K USD +23%
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 34.3M shares +17.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.51M USD -27.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.6M USD +11.4%
Deferred Tax Assets, Valuation Allowance 9.05M USD +65.9%
Operating Lease, Liability 492K USD
Lessee, Operating Lease, Liability, to be Paid 517K USD
Property, Plant and Equipment, Gross 1.65M USD +4.09%
Operating Lease, Liability, Current 136K USD +8.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 146K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 140K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.3K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 152K USD
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 78.3K USD
Additional Paid in Capital 81.1M USD +35.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 106K USD +3.31%